论文部分内容阅读
目的:评价竭香定痛胶囊对冠心病不稳定型心绞痛患者临床症状改善情况及对C反应蛋白、低密度脂蛋白的影响。方法:将2008年4月至2010年1月我院150例诊断为冠心病不稳定型心绞痛患者随机分为观察组和对照组,建立其中西医结合诊疗方案,并进行临床疗效观察及相关检查验证。结果:观察组病人临床症状改善状况和临床疗效均优于对照组(P<0.05或0.001),观察组对冠心病不稳定型心绞痛患者C反应蛋白及低密度脂蛋白的影响优于对照组(P<0.05)。结论:竭香定痛胶囊对冠心病不稳定型心绞痛患者临床疗效肯定,观察组疗效优于对照组;竭香定痛胶囊对冠心病不稳定型心绞痛患者C反应蛋白及低密度脂蛋白有显著影响。
Objective: To evaluate the clinical effect of Dixiangdingtong capsule on clinical symptoms and its effect on C-reactive protein and low density lipoprotein in patients with coronary heart disease and unstable angina pectoris. Methods: From April 2008 to January 2010, 150 patients diagnosed as unstable angina pectoris in our hospital were randomly divided into observation group and control group, and the combination of TCM and WM was established. Clinical efficacy and related tests were also performed . Results: The improvement of clinical symptoms and clinical efficacy in the observation group were better than those in the control group (P <0.05 or 0.001). The effect of the observation group on C-reactive protein and low density lipoprotein in patients with unstable angina pectoris was better than that in the control group P <0.05). Conclusion: Weixiangtongtong Capsule affirmed the clinical curative effect in patients with coronary heart disease and unstable angina pectoris, and the observation group had better curative effect than the control group.Weixiangdingtong capsule had significant effect on C-reactive protein and low density lipoprotein in patients with coronary heart disease and unstable angina pectoris influences.